Skip to content

Nemaline Myopathy 9 C3810384

Published: July 22, 2026Updated: August 20, 2026

A rare genetic muscle disease from FHL1 gene changes. Causes progressive muscle weakness and can affect the heart. Treatment involves multidisciplinary supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized muscle weakness

(musculoskeletal)

Joint pain or stiffness

(musculoskeletal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Delayed motor milestones

(musculoskeletal)

Facial weakness

(musculoskeletal)

Joint contractures

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Cardiorespiratory monitoring program

Systematic monitoring including echocardiograms, pulmonary function tests, and sleep studies to detect cardiac and respiratory complications early in nemaline myopathy 9.

monitoring
2

Evidence-based pharmacological treatment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Individualized exercise prescription

Customized exercise program designed to maintain strength without causing muscle damage, potentially including assisted standing and gentle resistance training.

physical_therapy

Additional treatment options

Protein-enhanced nutritional support

Dietary consultation focusing on adequate protein intake and overall caloric balance to support muscle maintenance in nemaline myopathy 9.

dietary

Non-invasive ventilation support

Initiation of BiPAP or other non-invasive ventilation when nocturnal hypoventilation or respiratory muscle weakness becomes symptomatic.

procedure

Cognitive behavioral and coping therapy

Psychological support addressing adjustment to progressive disability, depression, and anxiety associated with chronic severe neuromuscular disease.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Nemaline Myopathy 9 C3810384?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Nemaline Myopathy 9 C3810384. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy